DRIO•benzinga•
Looking Into DarioHealth's Return On Capital Employed
Summary
Benzinga Pro data, DarioHealth (NASDAQ:DRIO) reported Q2 sales of $6.18 million. Earnings fell to a loss of $18.03 million, resulting in a 13.27% decrease from last quarter.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 9, 2022 by benzinga